Efficacy and safety results from the primary analysis of the pivotal Summit trial: Bezuclastinib in adults with non-advanced systemic mastocytosis
Journal/Conference - American Society of Hematology Annual Meeting
Journal/Conference - American Society of Hematology Annual Meeting